<DOC>
	<DOCNO>NCT02831699</DOCNO>
	<brief_summary>This study evaluate subject fever and/or rash determine percentage infect Zika , Chikungunya , Dengue virus . The study also compare clinical sign , symptom , lab abnormality relate virus , good specify virus 's characteristic .</brief_summary>
	<brief_title>The Evaluation Potential Zika , Chikungunya , Dengue Infections Mexico</brief_title>
	<detailed_description>The study enroll subject several different cohort include febrile rash cohort ( attempt capture acute Zika/Chikungunya/Dengue infection ) , household cohort ( attempt capture asymptomatic minimally symptomatic subject ) , cohort Guillain Barré ) . Additionally , two subpopulation febrile rash cohort special follow . This include pregnant population , follow delivery determine pregnancy outcomes , subject neurologic cognitive manifestation evaluate determine spectrum neurologic disease see disease . Subjects Guillain Barré potential exposure Zika virus special interest give severity disease . Subjects Guillian Barré need precede illness suggestive Zika virus . As subject Guillain Barré , subject enrol two way - prospective cohort subject acute Guillain Barré , cohort subject Guillain Barré last several year . Data collect systematically cohort improve understand Zika/Chikungunya/Dengue virus infection . There many uncertainty number subject meet case definition . There limit ability enroll base staffing resource . If many case , emphasis place enrol pregnant subject adults neurologic complication meet case definition , area high clinical need . If pregnant woman subject neurologic problem enrol , adult child meet criterion enrol . Not cohort active site , base type facility type patient typically see . If sufficient number certain population enrol ( i.e . child born woman infect Zika ) , protocol may amend study population detail .</detailed_description>
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Chikungunya Fever</mesh_term>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Zika Virus Infection</mesh_term>
	<criteria>Febrile Rash Cohort Subjects fever and/or rash include meet one follow ( 1 2 ) : 1 . Meeting WHO/PAHO case definition , define ( b c ) : 1 . One follow primary sign : Rash Elevated body temperature ( &gt; 37.2 °C ) AND 2 . One follow symptom ( explain medical condition ) : Arthralgia Myalgia Nonpurulent conjunctivitis conjunctival hyperemia Headache Malaise AND 3 . Onset illness last 7 day 2 . Modified case definition ( b ) : 1 . Any two following : Rash Elevated body temperature ( &gt; 37.2 °C ) Arthralgia Myalgia Nonpurulent conjunctivitis conjunctival hyperemia Headache Malaise AND 2 . Onset illness last 7 day Household Cohort Living household subject enrol febrile rash cohort GuillainBarré Prospective Cohort Either confirm suspect GuillainBarré ( areflexic flaccid paralysis ) define either follow : 1 . Confirmed GuillainBarré 1 . Acute onset weakness paralysis ( baseline full weakness 7 day ) 2 . Weakness symmetrical 3 . Areflexic ( reflexes 0/4 ) 4 . Diagnosis within last 10 day 2 . Suspected GuillainBarré 1 . Acute onset illness 2 . Areflexic flaccid paralysis 3 . Diagnosis within last 10 day Prior GuillainBarré Cohort 1 . Confirmed GuillainBarré 1 . Acute onset weakness paralysis ( baseline full weakness 7 day ) 2 . Weakness symmetrical 3 . Areflexic ( reflexes 0/4 ) 4 . Diagnosis since January 2014 2 . Suspected GuillainBarré 1 . Acute onset illness 2 . Areflexic flaccid paralysis 3 . Clinical diagnosis GuillainBarré 4 . Diagnosis since January 2014 Exclusion Criteria cohort : Adult participant unable consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Zika</keyword>
	<keyword>Guillain Barré</keyword>
</DOC>